MARK LEVITAN, MD
Ophthalmology Physician · AUSTIN, TX
Individual Active NPI 1609848399
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 945 | 21,319 | $9,795,427 | $3,773,409 | $2,976,772 |
| 2023 | 906 | 13,122 | $8,408,515 | $3,358,611 | $2,640,263 |
| 2022 | 1,256 | 13,215 | $9,680,295 | $4,288,978 | $3,362,208 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 6,540 | $34 | $27 |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | 4,425 | $147 | $117 |
| 92134 | Imaging of retina | 1,985 | $40 | $29 |
| J0178 | Injection, aflibercept, 1 mg | 1,894 | $822 | $654 |
| 67028 | Injection of drug into eye | 1,448 | $134 | $103 |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 1,430 | $231 | $184 |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | 836 | $166 | $126 |
| J0177 | Injection, aflibercept hd, 1 mg | 776 | $332 | $265 |
| J2782 | Injection, avacincaptad pegol, 0.1 mg | 680 | $109 | $87 |
| 92014 | Established patient complete exam of visual system | 555 | $128 | $89 |
| 92250 | Photography of the retina | 256 | $37 | $28 |
| 92004 | New patient complete exam of visual system | 105 | $151 | $107 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | J3839 | TX |
| Retina Specialist (Ophthalmology) Physician | 207WX0107X | J3839 | TX |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in Texas
- NPI 1700085248
- NPI 1245175801
- NPI 1699126425
- NPI 1245437524
- NPI 1467147793
- NPI 1992708242
- NPI 1255795217
- NPI 1427615426
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.